We are live on ! Find out more
SBFMW

Sunshine Biopharma Inc Warrant
SBFMW

4 hedge funds and large institutions have $27K invested in Sunshine Biopharma Inc Warrant in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

0.64% less ownership

Funds ownership: 1.01% → 0.37% (-0.64%)

45% less capital invested

Capital invested by funds: $49K → $27K (-$22K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.68K
2
UBS Group
UBS Group
Switzerland
-$212
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$16K -$1.68K -2,272 -5%
EAM
2
Empery Asset Management
New York
$7K – – –
UBS Group
3
UBS Group
Switzerland
$4K -$212 -287 -3%

SBFMW Hedge Fund Activity: Q3 2022 in Review

4 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q3 2022, worth a combined $27K — down 45% from $49K a quarter earlier.

Fund positioning in SBFMW was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.

The largest seller was Susquehanna International Group, cutting an estimated $1.68K.

  • 4 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $27K of Sunshine Biopharma Inc Warrant stock for Q3 2022, down 45% quarter-over-quarter.
  • 0 funds opened new Sunshine Biopharma Inc Warrant positions in Q3 2022 and 0 closed out.
  • The largest Sunshine Biopharma Inc Warrant seller in Q3 2022 was Susquehanna International Group, an estimated $1.68K sold.

Based on aggregated 13F filings for Q3 2022.